It has become evident that RNA- and DNA-containing immune complexes, which often exist in sera of patients with systemic lupus erythematosus (SLE), can activate TLR7 and TLR9 signaling [2]. This evidence concerns the gene TLR7 and systemic lupus erythematosus.